• Featured Product
  • KD/KO Validated

PLAA Monoclonal antibody

PLAA Monoclonal Antibody for WB, IHC, ELISA

Host / Isotype

Mouse / IgG1

Reactivity

human, mouse, rat

Applications

WB, IHC, ELISA

Conjugate

Unconjugated

CloneNo.

5C10G9

Cat no : 60244-1-Ig

Synonyms

DOA1, PLA2P, PLAA, PLAP



Tested Applications

Positive WB detected inROS1728 cells, K-562 cells, MCF-7 cells, A431 cells
Positive IHC detected inhuman kidney tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

The immunogen of 60244-1-Ig is PLAA Fusion Protein expressed in E. coli.

Tested Reactivity human, mouse, rat
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen PLAA fusion protein Ag3224
Full Name phospholipase A2-activating protein
Calculated Molecular Weight 738 aa, 81 kDa
Observed Molecular Weight 75-80 kDa
GenBank Accession NumberBC032551
Gene Symbol PLAA
Gene ID (NCBI) 9373
RRIDAB_2881366
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Phospholipase A-2-activating protein (PLAA), also named PLAP, can interact with ubiquitin and is involved in the maintenance of ubiquitin levels. PLAA contains multiple consensus domains including WD repeats, PFU domain and PUL domain. Although the function of PLAA remains unclear, ubiquitin binding of PLAA might be the central role that connects ubiquitination and degradation in ERAD. Recent finding revealed that PLAA served as a novel nociveptive mediator after incision, and its expression level is regulated by miR-203.

Protocols

Product Specific Protocols
WB protocol for PLAA antibody 60244-1-IgDownload protocol
IHC protocol for PLAA antibody 60244-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols